España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Atossa Therapeutics
ATOS
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$1.17
0.01
0.86%
At Close: -
$1.16
-0.01
-0.85%
After Hours: Jul 3, 4:39 PM EDT
15 minutes delayed
Get Report
Watch
Atossa Therapeutics (ATOS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Atossa Therapeutics (NASDAQ:ATOS) Stock
Atossa Therapeutics Stock (NASDAQ: ATOS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 02, 2024
Atossa Therapeutics Appoints Heather Rees As ...
Benzinga Newsdesk
Friday, June 28, 2024
HC Wainwright & Co. Reiterates Buy on Atossa ...
Benzinga Newsdesk
Atossa Therapeutics Announces Updated Protoco...
Benzinga Newsdesk
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on At...
Benzinga Newsdesk
Monday, June 17, 2024
Atossa To Join Russell 3000 Index
Benzinga Newsdesk
Thursday, June 06, 2024
Ascendiant Capital Maintains Buy on Atossa Th...
Benzinga Newsdesk
Wednesday, May 15, 2024
Atossa Therapeutics Last Patient Its Phase 2 ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Cantor Fitzgerald Reiterates Overweight on At...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Maintains Buy on Atossa T...
Benzinga Newsdesk
Atossa Therapeutics Q1 2024 Adj EPS $(0.05) B...
Benzinga Newsdesk
Tuesday, May 07, 2024
Atossa Therapeutics Announces Support Of New ...
Benzinga Newsdesk
Monday, April 29, 2024
Atossa Therapeutics Announces Expanded Resear...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on Atossa ...
Benzinga Newsdesk
Monday, April 15, 2024
Atossa Therapeutics And Quantum Leap Healthca...
Benzinga Newsdesk
Tuesday, April 09, 2024
Atossa Therapeutics Presents Data From 40mg C...
Benzinga Newsdesk
Tuesday, April 02, 2024
HC Wainwright & Co. Maintains Buy on Atossa T...
Benzinga Newsdesk
Tuesday, March 19, 2024
Atossa Therapeutics shares are trading higher...
Benzinga Newsdesk
Atossa Therapeutics Provides Five-Year (Z)-En...
Benzinga Newsdesk
Monday, March 18, 2024
Atossa Therapeutics Regains Compliance With N...
Benzinga Newsdesk
Wednesday, March 06, 2024
Data From Atossa's Phase 2 EVANGELINE Clinica...
Benzinga Newsdesk
Thursday, February 22, 2024
Atossa Therapeutics Announces First Patient D...
Benzinga Newsdesk
Monday, February 12, 2024
HC Wainwright & Co. Initiates Coverage On Ato...
Benzinga Newsdesk
Wednesday, February 07, 2024
Atossa Therapeutics Fully Enrolls (Z)-Endoxif...
Benzinga Newsdesk
Tuesday, January 09, 2024
Atossa Therapeutics Issues Letter To Sharehol...
Benzinga Newsdesk
Monday, November 20, 2023
Atossa Therapeutics Announces Full Enrollment...
Benzinga Newsdesk
Thursday, November 16, 2023
Atossa Therapeutics Board Member Awarded $42K Worth of Stock Options
Benzinga Insights
Director at Atossa Therapeutics Acquires Company Stock Options Worth 62,500 Shares
Benzinga Insights
Monday, November 13, 2023
Atossa Therapeutics Q3 EPS $(0.05) Beats $(0....
Benzinga Newsdesk
Tuesday, October 24, 2023
This Drug Developer Is Dedicated To "Transforming The Breast Cancer Paradigm"
Johnny Rice
Friday, October 06, 2023
Atossa Therapeutics Announces Greg Weaver Pro...
Benzinga Newsdesk
Friday, September 15, 2023
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
Faith Ashmore
-
Sponsored
Friday, September 08, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Breast Cancer-Focused Atossa Therapeutics Can Possibly Change Treatment Paradigm: Analyst
Vandana Singh
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
Benzinga Insights
Cantor Fitzgerald Initiates Coverage On Atoss...
Benzinga Newsdesk
Thursday, August 31, 2023
Atossa Therapeutics Filed A Petition For Post...
Benzinga Newsdesk
Monday, August 14, 2023
Atossa Therapeutics Q2 EPS $(0.08) Down From ...
Benzinga Newsdesk
Earnings Scheduled For August 14, 2023
Benzinga Insights
Wednesday, August 09, 2023
Could Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?
Faith Ashmore
-
Sponsored
Thursday, July 20, 2023
Atossa Therapeutics Receives Approval From Health Canada to Conduct Phase 2 EVANGELINE Clinical Trial In Canada
Happy Mohamed
Thursday, July 13, 2023
Atossa Therapeutics Regains Compliance With N...
Benzinga Newsdesk
Tuesday, July 11, 2023
50% Of Women Have Elevated Breast Density, Which Significantly Decreases The Effectiveness Of Mammography – Atossa Therapeutics Is Looking To Ensure Earlier, Accurate Diagnosis
Faith Ashmore
-
Sponsored
Monday, July 10, 2023
Atossa Therapeutics Provides Enrollment Update For Ongoing Phase 2 Karisma-Endoxifen Clinical Trial; 170 Patients Have Been Enrolled In The Company's Ongoing Phase 2 Karisma-Endoxifen Clinical Trial. Atossa Expects The Study To Fully Enroll In Q4 2023
Happy Mohamed
Thursday, July 06, 2023
Atossa Therapeutics Announces Sponsored Resea...
Benzinga Newsdesk
Wednesday, June 28, 2023
Atossa Therapeutics shares are trading higher...
Benzinga Newsdesk
Atossa Therapeutics, Quantum Leap Healthcare ...
Benzinga Newsdesk
Tuesday, June 27, 2023
Atossa Therapeutics Announces $10M Stock Repu...
Bill Haddad
Wednesday, June 21, 2023
Atossa Therapeutics Granted Additional Patent Protection For Endoxifen
Happy Mohamed
Monday, June 12, 2023
Atossa Completes Enrollment Of Pharmacokineti...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch